Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Phibro Animal (S, US)  Pharmaceuticals
1. Phibro Animal (S, US)   Pharmaceuticals 84 30 21 38
2. Pfizer (XL, US)  Pharmaceuticals
2. Pfizer (XL, US)   Pharmaceuticals 46 52 63 61
3. AbbVie (XXL, US)  Biotechnology
3. AbbVie (XXL, US)   Biotechnology 46 73 8 34
4. Akorn (M, US)  Pharmaceuticals
4. Akorn (M, US)   Pharmaceuticals 38 23 43 20
5. Lannett (S, US)  Pharmaceuticals
5. Lannett (S, US)   Pharmaceuticals 38 43 21 20

April 28, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Supernus Pharma (S, US)   Pharmaceuticals
1. Supernus Pharma (S, US)   Pharmaceuticals 19 100 53 66
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 34 78 92 91
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology 46 73 8 34
4. Johnson & Johnson (XL, US)   Pharmaceuticals
4. Johnson & Johnson (XL, US)   Pharmaceuticals 35 66 26 31
5. Pfizer (XL, US)   Pharmaceuticals
5. Pfizer (XL, US)   Pharmaceuticals 46 52 63 61
6. Prestige (M, US)   Pharmaceuticals
6. Prestige (M, US)   Pharmaceuticals 4 52 17 3

April 28, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 34 78 92 91
2. Merck (XL, US)   Pharmaceuticals
2. Merck (XL, US)   Pharmaceuticals 20 27 77 28
3. Eli Lilly (XL, US)   Pharmaceuticals
3. Eli Lilly (XL, US)   Pharmaceuticals 18 28 68 25
4. Pfizer (XL, US)   Pharmaceuticals
4. Pfizer (XL, US)   Pharmaceuticals 46 52 63 61
5. Supernus Pharma (S, US)   Pharmaceuticals
5. Supernus Pharma (S, US)   Pharmaceuticals 19 100 53 66

April 28, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 34 78 92 91
2. Supernus Pharma (S, US)   Pharmaceuticals
2. Supernus Pharma (S, US)   Pharmaceuticals 19 100 53 66
3. Pfizer (XL, US)   Pharmaceuticals
3. Pfizer (XL, US)   Pharmaceuticals 46 52 63 61
4. Phibro Animal (S, US)   Pharmaceuticals
4. Phibro Animal (S, US)   Pharmaceuticals 84 30 21 38
5. AbbVie (XXL, US)   Biotechnology
5. AbbVie (XXL, US)   Biotechnology 46 73 8 34

April 28, 2017. Top 10s are published weekly by . ()

This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer then 10 stocks due to Obermatt’s top 10 quality standards

.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from April 28, 2017.

Top 10 Stock History D.J. US Pharmaceutical